Tripair™ developed by Coramaze Revenue

Medical Equipment Manufacturing • Hilden, North Rhine-Westphalia, Germany • 21-50 Employees

Tripair™ developed by Coramaze revenue & valuation

Annual revenue	$1,796,655
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Medical Equipment Manufacturing industry and current estimated revenues	$5,800,000
Total funding	No funding

Key Contacts at Tripair™ developed by Coramaze

Jochen Reinöhl

Chief Executive Officer

Lucía García Inciarte

Director Clinical Operations

Jacob Van Dam

Director Of Qa

Konstantin Winterhalder

Director Operations And Finance

Company overview

Headquarters	Mühlenhof 7-9, D-40721, Hilden, DE
Website	tripairtechnology.com
NAICS	3391
Keywords	Medical Devices, Medtech, Medical Technology, TR, Heart Disease, Cardiovascular Medical Technology, Structural Heart Valve Diseases, Structural Heart, Tricuspid Regurgitation, Transcatheter Tricuspid Valve Repair, Tricuspid Edge To Spacer Repair
Employees	21-50

Tripair™ developed by Coramaze Email Formats

Tripair™ developed by Coramaze uses 1 email format. The most common is {last name} (e.g., doe@coramaze.com), used 100% of the time.

Format	Example	Percentage
{last name}	doe@coramaze.com	100%

About Tripair™ developed by Coramaze

Tripair™ is a novel, minimally invasive tricuspid valve repair technology designed to treat tricuspid regurgitation — a condition that affects millions globally, with the vast majority currently remaining untreated. Tripair™ simplifies tricuspid valve repair through an innovative transcatheter edge-to-spacer approach. By overcoming the key challenges of procedural complexity and limited adoption, we are on a mission to make TR treatment as simple as a right heart catheterization — so it can be performed by any interventionalist, anywhere. Tripair™ is developed by Coramaze Technologies, a pre-commercial stage company with offices in Germany and Israel. The technology is currently investigational and not yet available for commercial use.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

C-Suite

Director

Employees by Department

Tripair™ developed by Coramaze has 14 employees across 4 departments.

Departments

Number of employees

Funding Data

Tripair™ developed by Coramaze has never raised funding before.

Frequently asked questions

Tripair™ developed by Coramaze is located in Hilden, North Rhine-Westphalia, DE.

Tripair™ developed by Coramaze generates an estimated annual revenue of $1,796,655. This revenue figure reflects the company's market position and business performance in its industry.

Tripair™ developed by Coramaze has an estimated valuation of $5,800,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Tripair™ developed by Coramaze has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.